BiltRx Compounded Tirzepatide Review

BiltRx sells compounded tirzepatide through an online telehealth platform backed by a US 503A compounding pharmacy. The monthly cost for the compounded formulation sits at $129, which makes it one of the least expensive options currently on the market. BiltRx also offers brand-name Mounjaro and Zepbound at $1,499 per month for patients who prefer the FDA-approved product. We reviewed the company's stated offerings, pricing structure, ordering process and publicly available information to produce this assessment.

BiltRx Compounded Tirzepatide Overview

BiltRx operates as a telehealth service that connects patients with licensed prescribers and fills tirzepatide prescriptions through a partnered 503A compounding pharmacy in the United States. Section 503A pharmacies prepare medications based on individual patient prescriptions and are overseen by state pharmacy boards. They differ from 503B outsourcing facilities, which face direct FDA inspection and follow current good manufacturing practice standards.

The core product is compounded tirzepatide in injectable form. There are no oral tablets or capsules offered. Patients receive their supply on a monthly delivery schedule. Consultation and shipping fees apply on top of the $129 base price, though BiltRx does not break down those fees prominently on its marketing pages.

For patients who want the branded drug, BiltRx lists Mounjaro and Zepbound at $1,499 per month. That figure aligns roughly with the out-of-pocket cost many patients face without insurance. The availability of both compounded and brand-name options under one platform is a practical feature for patients who may want to switch between them based on budget or preference.

How to Order and What to Expect

The ordering process follows the standard telehealth model. Patients begin with an online medical consultation. A licensed prescriber reviews health history, current medications and eligibility for tirzepatide based on BMI and comorbidity criteria. If approved, the prescriber writes a prescription that is sent to the partnered 503A pharmacy for compounding.

After the pharmacy fills the prescription, the medication ships directly to the patient. BiltRx advertises monthly delivery, which means a new supply arrives each month without requiring a repeat consultation for every refill. The initial consultation fee and ongoing shipping fees are separate from the $129 medication cost. BiltRx does not prominently display these additional fees, so the total out-of-pocket figure will be higher than $129 in practice.

Patients should expect the standard tirzepatide escalation protocol. Treatment typically starts at 2.5 mg for the first four weeks and increases in 2.5 mg increments every four weeks based on tolerability and physician guidance. The maximum approved dose for brand-name tirzepatide is 15 mg per week. Whether BiltRx's compounded version follows the same escalation schedule depends on the prescribing physician's clinical judgment.

One thing BiltRx does not advertise is a money-back guarantee or satisfaction policy. Arc-1 offers a 30-day guarantee, which provides a safety net for first-time patients. The absence of a similar policy from BiltRx is worth noting for anyone hesitant about trying compounded tirzepatide for the first time.

Our Verdict

BiltRx Compounded Tirzepatide receives an editorial rating of 4.3 out of 5. Sub-scores: Price 4.8, Convenience 4.5, Transparency 3.8, Support 4.0.

The price score is the standout. At $129 per month for compounded tirzepatide, BiltRx offers the lowest base cost among providers we review. That number alone will be the deciding factor for many patients who are paying out of pocket. The convenience score reflects a smooth online consultation model and monthly delivery that reduces friction. No state restrictions are listed, which broadens access compared to providers with geographic limitations.

The transparency score of 3.8 is the weakest area. BiltRx does not publish dose-tier pricing, formulation details or a clear breakdown of consultation and shipping fees before patients enter the ordering funnel. Prospective patients cannot calculate their true monthly cost from the website alone. The support score of 4.0 reflects a functional but unremarkable customer support experience with no documented guarantee policy.

For patients whose primary concern is monthly cost and who are comfortable with a 503A pharmacy source, BiltRx represents strong value. Patients who want full pricing transparency and a money-back guarantee before committing may prefer Arc-1, despite its higher price. Both providers sell compounded tirzepatide that is not FDA-approved, and patients should discuss the compounded-versus-brand decision with their prescribing physician. Our provider comparison page places both side by side.